EP3521312
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.2.2014EP published:
7.4.2021EP application number:
19163475.7
EPO information:
European Patent Register
Max expiry date:
19.2.2034
Title:
A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA
Timeline
Today
20.2.2014EP application
7.4.2021EP Publication
Owner
Name:
Innate PharmaAddress:
117 Avenue de Luminy, 13009 Marseille, FR
Inventor
Name:
BONNAFOUS, CécileAddress:
13009 Marseille, FR
Name:
SICARD, HélèneAddress:
13009 Marseille, FR
Name:
BUFFET, RenaudAddress:
92100 Boulogne, FR
Priority
Number:
201361766798 PDate:
20.2.2013Country:
US
Number:
201361831809 PDate:
6.6.2013Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, A61P 35/00, A61K 39/395